Atelvia
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0430-0979 -
Package NDC
0430-0979-03 -
Application number
NDA022560 -
SPL ID
936662af-4e07-4361-b7ef-760ebfad3e01 -
SPL set ID
c8b9ab88-1a26-46c3-80ec-4eaa45202021 -
UNII
HU2YAQ274O -
UNII
F67L43UT5C -
RxCUI
1020064 -
RxCUI
1020065 -
RxCUI
1020066
What the source publishes
- Labeler
- Allergan, Inc.
- Active ingredients
- risedronate sodium
- Form
- TABLET, DELAYED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Atelvia",
"splId": "936662af-4e07-4361-b7ef-760ebfad3e01",
"labels": [
{
"setId": "c8b9ab88-1a26-46c3-80ec-4eaa45202021",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8b9ab88-1a26-46c3-80ec-4eaa45202021",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c8b9ab88-1a26-46c3-80ec-4eaa45202021"
}
],
"routes": [
"ORAL"
],
"labeler": "Allergan, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "4 TABLET, DELAYED RELEASE in 1 DOSE PACK (0430-0979-03)",
"package_ndc": "0430-0979-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20101201"
}
],
"productId": "0430-0979_936662af-4e07-4361-b7ef-760ebfad3e01",
"useDomain": "unknown",
"dosageForm": "TABLET, DELAYED RELEASE",
"productNdc": "0430-0979",
"deaSchedule": null,
"genericName": "risedronate sodium",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "RISEDRONATE SODIUM HEMIPENTAHYDRATE",
"strength": "30.1 mg/1"
},
{
"name": "RISEDRONATE SODIUM MONOHYDRATE",
"strength": "4.9 mg/1"
}
],
"applicationNumber": "NDA022560",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20101201",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"HU2YAQ274O",
"F67L43UT5C"
],
"rxcui": [
"1020064",
"1020065",
"1020066"
],
"spl_set_id": [
"c8b9ab88-1a26-46c3-80ec-4eaa45202021"
],
"manufacturer_name": [
"Allergan, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0430-0979_936662af-4e07-4361-b7ef-760ebfad3e01"